siRNA treatment lowers triglycerides in clients with unusual disorder

.ANALYSIS EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride amounts through 80% and reduced the threat of pancreatitis in clients along with chronic chylomicronemia, along with or without a hereditary prognosis.